Results 281 to 290 of about 430,120 (302)

Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study

Lancet, The, 2016
Francisco Campelo-Parada, William T Abraham, Josep Rodés-Cabau   +2 more
exaly  

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

Lancet, The, 2020
Muthiah Vaduganathan, Pardeep S Jhund, Jonathan W Cunningham   +2 more
exaly  

ejection fraction

2009
openaire   +1 more source

Spironolactone for Heart Failure with Preserved Ejection Fraction

New England Journal of Medicine, 2014
Bertram Pitt, Marc Pfeffer, Inder S Anand   +2 more
exaly  

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Lancet, The, 2003
Salim Yusuf, Karl Swedberg, Christopher B Granger   +2 more
exaly  

Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

New England Journal of Medicine, 2008
Michel Komajda, Michael R Zile
exaly  

Ejection fraction

Revista Española de Cardiología
openaire   +1 more source

Gated SPECT thallium ejection fraction calculation comparative to calculated echo ejection fraction

Journal of Nuclear Cardiology, 1997
W VanDecker, A Khan, J Krackow, J Nocella, A Sokil   +4 more
openaire   +1 more source

A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial

Lancet, The, 2016
Scott C Mckenzie, Finn Gustafsson, Filip Málek   +2 more
exaly  

Cardiac Ejection Fraction

2006
openaire   +1 more source